Novel Entamoeba Findings in Nonhuman Primates. by Elsheikha, Hany M et al.
Elsheikha, HM; Regan, CS; Clark, CG (2018) Novel Entamoeba Find-
ings in Nonhuman Primates. Trends in parasitology, 34. pp. 283-294.
ISSN 1471-4922 DOI: https://doi.org/10.1016/j.pt.2017.12.008
Downloaded from: http://researchonline.lshtm.ac.uk/4646383/
DOI: 10.1016/j.pt.2017.12.008
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
1 
 
Review 1 
 2 
Novel Entamoeba findings in non-human primates  3 
 4 
 5 
Hany M. Elsheikha,1 Carl S. Regan,1,2 and C. Graham Clark 3, * 6 
 7 
 8 
 9 
1 Faculty of Medicine and Health Sciences, School of Veterinary Medicine and Science, 10 
University of Nottingham, Sutton Bonington Campus, Loughborough, LE12 5RD, UK 11 
 12 
2 Current address: Vets4pets Dover Whitfield, White Cliffs Retail Park, Whitfield, Dover, 13 
CT16 3PS, UK 14 
 15 
3 Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical 16 
Medicine, London, UK 17 
 18 
*Correspondence: 19 
graham.clark@lshtm.ac.uk 20 
(C. Graham Clark) 21 
 22 
Keywords:  Entamoeba, Evolution, Non-human primates, Phylogeny, Species delineation  23 
2 
 
Abstract 24 
 25 
In addition to well-known human-infecting species, Entamoeba species not found in humans 26 
have been identified recently in non-human primates (NHPs). Importantly, it has become clear 27 
that the organism identified as Entamoeba histolytica in NHPs is usually a distinct species, 28 
Entamoeba nuttalli. Many DNA-based stool surveys use species-specific detection methods 29 
and so may miss the full range of Entamoeba species present. In addition, authors may be using 30 
the same species name to describe distinct organisms. These various shortcomings may not be 31 
obvious to readers. In this review, we clarify the relationships between Entamoeba species’ 32 
names based on morphological and molecular data, and highlight gaps in recently published 33 
data on Entamoeba species in wild NHPs resulting from the use of variable methodology. 34 
 35 
Humans and NHPs are both primates, but how similar are their Entamoeba species? 36 
 37 
Humans are primates, and therefore it would be logical to assume that the parasite fauna of 38 
humans and non-human primates (NHPs; see Glossary) is likely to be similar. However, this 39 
simplistic view ignores the huge range of life-styles, diets and ecological specialisations 40 
exhibited by NHPs, and the millions of years of independent evolution that separate us from 41 
even our closest NHP relatives, the great apes. Nevertheless, humans and NHPs do appear to 42 
have many parasites in common, at least when identified via microscopy. Over recent decades, 43 
molecular tools have allowed us to re-examine these similarities and to challenge the 44 
assumption that apparent morphological identity equates to species identity. This review 45 
discusses how molecular tools provide a clearer picture of the relationships between intestinal 46 
amoebae of the genus Entamoeba in humans and NHPs and where gaps in our understanding 47 
remain. 48 
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 49 
What is causing invasive amoebiasis in humans and NHPs? 50 
 51 
The focus on Entamoeba is largely due to Entamoeba histolytica being a significant cause of 52 
morbidity and mortality in humans. Published estimates suggest this organism is responsible 53 
for millions of cases of disease and over 50,000 deaths in humans annually [1]. Although these 54 
numbers are extrapolated from a limited number of studies, E. histolytica is certainly 55 
responsible for a significant amount of disease in some locations. Captive NHPs occasionally 56 
die from a disease that is, superficially, indistinguishable from that caused by E. histolytica in 57 
humans (e.g. [2]). Several other Entamoeba species that resemble E. histolytica 58 
morphologically have been described in both humans and NHPs, making microscopic 59 
diagnosis problematic. Morphologically distinct, non-pathogenic species of Entamoeba also 60 
appear to be shared by humans and NHPs, further complicating diagnosis (see below).  61 
 62 
The morphology era 63 
 64 
The existence of species of Entamoeba in humans and NHPs that appear identical by 65 
microscopy has been known for over a century. At that time, organisms in new hosts were often 66 
given new species names, whether morphologically distinguishable or not. A major work by 67 
Dobell [3] concluded that all named intestinal species of Entamoeba in humans could be 68 
assigned to either E. histolytica or Entamoeba coli, but he equivocated about Entamoeba from 69 
NHPs on the grounds of insufficient data; he later concluded that intestinal Entamoeba species 70 
in NHPs were also E. histolytica and E. coli [4]. His two-species nomenclature stayed 71 
essentially intact for 35 years.  72 
 73 
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In the mid-1950s, Burrows [5] resurrected the name Entamoeba hartmanni for an organism 74 
that parasitologists were referring to as ‘small race E. histolytica’. Dobell [3] had viewed E. 75 
hartmanni as a synonym of E. histolytica; however, Burrows showed that the sizes of E. 76 
histolytica ‘large race’ and ‘small race’ cysts were not a continuum but had a clear bimodal 77 
distribution. This first ‘break’ with the Dobell nomenclature was quickly adopted, because 78 
parasitologists were already primed to accept it.  79 
 80 
The molecular era 81 
 82 
Entamoeba hartmanni was the last change to Dobell’s nomenclature scheme based on 83 
morphology alone. Additional changes followed but not for many years, as the changes were 84 
primarily dependent on small subunit ribosomal RNA gene (SSU-rDNA) analyses. Emile 85 
Brumpt [6] proposed the existence of Entamoeba dispar, a non-pathogenic species 86 
morphologically identical to E. histolytica. This proposal was rejected by most parasitologists 87 
at the time (see discussion following [7]) and the name E. dispar virtually disappeared from 88 
the literature. Suspicion that Brumpt had been correct followed on from studies based on both 89 
lectin agglutination [8] and isoenzyme patterns [9], in which two groups within E. histolytica 90 
were identified, only one of which was found in patients with invasive disease. Subsequently, 91 
studies (cited in [10]) using monoclonal antibodies, DNA hybridization, SSU-rDNA restriction 92 
fragment length polymorphism, and eventually DNA sequencing all identified the same two 93 
groups of strains, and this led to the formal redescription of E. dispar as a species distinct from 94 
E. histolytica [10]. 95 
 96 
Other SSU-rDNA-based changes to the nomenclature of human Entamoeba species include 97 
the reassignment of ‘E. histolytica-like’ amoebae to the species Entamoeba moshkovskii [11] 98 
5 
 
and the recognition that uninucleate cysts occasionally seen in humans were not always 99 
immature E. histolytica but were in fact Entamoeba polecki [12]. Most recently, Entamoeba 100 
bangladeshi was described as a new human species [13]; if it were not for SSU-rDNA 101 
sequences this organism would have been identified as E. moshkovskii despite it being 102 
genetically quite distinct. 103 
 104 
The nomenclature for Entamoeba species in NHPs has followed suit, for the most part. 105 
Entamoeba hartmanni is commonly found in NHPs. Entamoeba dispar is also widespread in 106 
NHPs. Entamoeba chattoni had long been accepted as a NHP-specific species of Entamoeba 107 
with uninucleate cysts. It was designated a subtype of E. polecki a few years ago [14], but this 108 
change of nomenclature for E. chattoni has not been universally accepted; this will be discussed 109 
further below. 110 
 111 
Thus, for the most part, the NHP Entamoeba nomenclature changes simply mirrored those in 112 
humans without any investigations to evaluate whether they were in fact the same organisms. 113 
This was understandable initially because there was no reason to suspect there were differences 114 
and the investigative tools were not readily available to many researchers. However, now that 115 
molecular techniques are routine in most research laboratories and some diagnostic 116 
laboratories, investigations into the diversity and identity of Entamoeba in NHPs have become 117 
more common and are revealing some surprising and important findings.  118 
 119 
The evidence for Entamoeba genetic diversity in NHPs is based almost exclusively on SSU-120 
rDNA analyses. Analyses of other markers are rarely possible because most studies use DNA 121 
extracted directly from stool samples, but when available they show the same species 122 
relationships. SSU-rDNA is a multicopy gene, which makes it relatively easy to amplify from 123 
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stool samples. In addition, and in contrast to some eukaryotes, the Entamoeba SSU-rDNA is 124 
relatively fast evolving (as evidenced by long branches in phylogenetic trees) meaning that 125 
sufficient resolution is obtained to allow differentiation of Entamoeba taxa using this gene 126 
alone.  127 
 128 
Entamoeba nuttalli 129 
Entamoeba histolytica causes disease of two main types: 1. amoebic dysentery/colitis, resulting 130 
from trophozoite invasion of the colonic mucosa and leading to ulceration, bleeding and the 131 
production of loose stool with blood and mucus; 2. amoebic liver abscess, resulting from 132 
haematogenous spread of trophozoites from the colon via the portal system to the liver, where 133 
tissue lysis leads to formation of a sterile pus-filled abscess [15]. Both types of disease have 134 
been reported in NHPs, and there have been a number of reports over the years of spontaneous 135 
invasive disease occurring in captive NHPs. Histologically, the diseases in humans and NHPs 136 
appear identical, as do the amoebae under the microscope [e.g. 2]. Entamoeba histolytica of 137 
human origin has been shown experimentally to be capable of infecting NHPs, where it can 138 
cause indistinguishable pathology [e.g. 16]. The organism responsible was therefore presumed 139 
to be E. histolytica in all cases of disease in NHPs.  140 
 141 
In the last 10 years, however, molecular studies have been performed on amoebae from cases 142 
of invasive amoebiasis occurring spontaneously in NHPs. The amoebae in NHPs are 143 
consistently distinguishable from E. histolytica using a variety of DNA and protein markers: 144 
isoenzymes, SSU-rDNA and short tandem-repeat-containing loci [17-20]. Although closely 145 
related to E. histolytica – indeed it has been called “E. histolytica-like variant” [19] and “E. 146 
histolytica NHP variant” [21]  by some – this is clearly a distinct organism and the name E. 147 
nuttalli has been revived for this amoeba [17]. Entamoeba nuttalli was originally described by 148 
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Castellani [22] in the liver abscess of a toque macaque (Macaca sinica) in Sri Lanka and is one 149 
of the species considered synonymous with E. histolytica by Dobell [3, 23]. Although we 150 
cannot prove after 110 years that the amoeba observed by Castellani is the same as the one now 151 
being called E. nuttalli, this seems quite likely. A recent survey of wild toque macaques in Sri 152 
Lanka detected asymptomatic carriage of E. nuttalli in 18.5% of the 227 animals studied [24]. 153 
Entamoeba histolytica was not detected in the population. Entamoeba nuttalli has been found 154 
in a variety of other NHPs – guenon, baboon, colobus and chimpanzee – in addition to other 155 
species of both captive and wild macaques [19, 25, 26].  156 
 157 
The host and geographic ranges of E. nuttalli seem to be quite large, but so far it seems to be 158 
found primarily in primates of the Old World. Invasive disease has been reported in captive 159 
spider monkeys [25], but whether it infects wild New World NHPs is unknown. Only one 160 
human infection with E. nuttalli has been reported to date, in a zookeeper [27]. This is despite 161 
analyses of human samples that would have revealed its presence if it had been there. 162 
Isoenzyme analysis, which was used widely for Entamoeba species differentiation in the 1980s 163 
and early 1990s [e.g. 28], would have distinguished E. nuttalli from E. histolytica [17, 19], but 164 
although many thousands of human samples were studied in order to differentiate E. dispar 165 
and E. histolytica, no evidence of what is now being called E. nuttalli was reported. A second 166 
human infection has apparently been identified in Iraq, based on a sequence in GenBank stated 167 
to be of human origin [55; GenBank accession number: KP233837]. 168 
 169 
Note that most DNA-based diagnostic tools cannot distinguish E. nuttalli from E. histolytica, 170 
unless combined with sequencing, and neither can some commercial antigen-based diagnostic 171 
kits and monoclonal antibodies [17]. Therefore, although it seems unlikely that significant 172 
numbers of humans will be found to be infected with E. nuttalli, such infections may occur 173 
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occasionally among those who have close contact with NHPs, and may go unrecognized 174 
depending on the diagnostic method used. Primer pairs specific for E. nuttalli do now exist [17, 175 
25] so that positive identification of this species without sequencing is possible. 176 
 177 
NHPs can be infected experimentally with E. histolytica cysts of human origin [23, 29], 178 
although no invasive disease has resulted from such experiments. Captive NHP infections 179 
involving E. histolytica have been confirmed by DNA sequencing [30]. Therefore, it cannot be 180 
ruled out that some natural E. histolytica infections will occur in wild NHPs – most likely 181 
among those that come into contact regularly with humans or human waste – although there 182 
are no sequence-confirmed infections to date [e.g. 56]. It is impossible retrospectively to know 183 
which organism was responsible for the invasive amoebiasis cases in NHPs reported in the 184 
literature. Indeed, it is not possible to be certain that the amoeba observed was responsible for 185 
the disease in some cases – the presence of an Entamoeba and dysentery in the same host does 186 
not necessarily imply cause and effect. 187 
 188 
Entamoeba polecki 189 
Entamoeba polecki produces cysts with one nucleus, as does E. chattoni. Sequencing of their 190 
SSU-rDNAs revealed them to be closely related organisms [31]. The former species is 191 
traditionally associated with pigs and the latter with NHPs. Despite sporadic reports of E. 192 
polecki infections in humans for many years [32], when uninucleated cysts were seen in 193 
humans it was generally assumed that they represented immature cysts of E. histolytica rather 194 
than of E. polecki or E. chattoni. Verweij et al. [12] studied human Entamoeba infections where 195 
only uninucleated cysts were seen and found four distinct SSU-rDNA sequences. Two of these 196 
sequences were essentially identical to those of E. polecki and E. chattoni isolated from a pig 197 
and a monkey, respectively, while the other two sequences were related but distinct. This meant 198 
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that there were four closely-related organisms with two names between them and that E. 199 
polecki and E. chattoni were not host-specific since all four organisms were found in humans.  200 
 201 
Verweij et al. proposed [12] that the four should be viewed as variants of the same organism 202 
and called ‘E. polecki-like’, as the name E. polecki has precedence. Later, Stensvold et al. [14] 203 
proposed that they should be considered subtypes and numbered ST1-ST4, with the former E. 204 
polecki becoming E. polecki ST1 and the former E. chattoni becoming E. polecki ST2. The 205 
rationale for this approach is that there is no host specificity and no known difference except 206 
for small amounts of sequence divergence. This subtype nomenclature has not been fully 207 
accepted. One of the two ‘unnamed’ subtypes was in the interim named Entamoeba struthionis 208 
[33] as it was isolated from an ostrich, but this subtype (ST3) has subsequently been found in 209 
pigs [34] as well as humans. The fourth subtype has never had a species name and for a long 210 
time was only known from humans, where it is the most common subtype. Recently, however, 211 
ST4 was found to be the only E. polecki subtype in wild Celebes crested macaques (Macaca 212 
nigra) [35], proving that E. polecki ST2 (E. chattoni) is not the only subtype found in NHPs. 213 
It is possible that E. polecki ST1 and ST3 will also eventually be identified in NHP hosts. In 214 
the absence of host-specificity, use of the ‘E. polecki subtype’ nomenclature seems appropriate. 215 
 216 
Entamoeba dispar, Entamoeba hartmanni and Entamoeba coli 217 
For the most part, these three species meet the original expectation that human and NHP 218 
Entamoeba species are the same. Entamoeba dispar is quite a homogeneous species and there 219 
is no indication to date that E. dispar from humans is in any way distinct from that in NHPs. 220 
Although E. hartmanni shows a greater degree of SSU-rDNA variation than E. dispar, there is 221 
no obvious clustering of sequences that reflects human or NHP origin [14, 36], suggesting it is 222 
a discrete species with moderate intraspecific variation.  223 
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 224 
The situation in E. coli is more complex and less clear-cut. Entamoeba coli samples from 225 
humans group into two clusters, which have been named ST1 and ST2 [14]; ST1 appears to be 226 
slightly more common than ST2 in humans. When NHP E. coli samples are examined, the 227 
same two STs are identified, with ST2 being slightly more common, although this is based on 228 
relatively few samples. ST2 was recently identified in wild mountain gorillas (Gorilla beringei) 229 
[36]. The degree of divergence between the SSU-rDNAs of the two subtypes is substantial and 230 
distinct species names could be justified. However, other than this sequence divergence, there 231 
are no known differences between the two subtypes to date. Entamoeba coli cysts can vary 232 
quite dramatically in size [37, 38]. Whether this size variation is a morphological reflection of 233 
the underlying sequence divergence remains to be established.  234 
 235 
Another Entamoeba that has been detected in NHPs is Entamoeba RL7 [14]. No species name 236 
has been assigned to this organism – it is simply known by its ribosomal lineage (RL) number 237 
[14]. Entamoeba RL7 was originally identified in a sample from a Phayre’s leaf monkey 238 
(Trachypithecus phayrei) [14], but it has subsequently been detected in humans in West Africa 239 
[34]. Uniquely, this Entamoeba is most closely related to Entamoeba muris (Figure 1), which, 240 
like E. coli, produces cysts with eight nuclei. Based on morphology, this organism previously 241 
would have been reported as E. coli.  242 
 243 
NHP-restricted Entamoeba Species  244 
 245 
There are several NHP-restricted Entamoeba sequences worthy of discussion here. The first is 246 
Entamoeba RL3, which to date has only been detected in langurs of various species and 247 
produces cysts with a single nucleus. In the past it would likely have been reported as E. 248 
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chattoni based on microscopy. No infections with this organism have been reported in humans, 249 
or indeed in any other NHP. It is closely related to, but distinct from, Entamoeba bovis and 250 
related lineages that are confined to ungulates [14]. RL3 has only been found in a few samples 251 
but it is notable that two lineages of Entamoeba (RL3 and RL7) have to date been detected 252 
exclusively in langurs. Whether this is linked to their unusual foregut fermentative digestion is 253 
unclear. 254 
 255 
Villanueva-García et al. [39] recently reported SSU-rDNA sequences of an apparently novel 256 
Entamoeba in two species of Howler monkey. Because these were only partial sequences they 257 
were given a conditional lineage identifier [34] rather than a RL number. Entamoeba CL8 is 258 
clearly distinct from previously sequenced Entamoeba SSU-rDNAs and, interestingly, the CL8 259 
sequence branches within a cluster of sequences obtained from reptilian Entamoeba strains. 260 
Villanueva-García et al. found a second Entamoeba sequence in their samples that is virtually 261 
identical to Entamoeba RL6, which was originally described from the green iguana (Iguana 262 
iguana) [14, 40]. The complete SSU-rDNA sequence of both these organisms would be helpful 263 
in order to confirm their phylogenetic tree placement. 264 
 265 
Finally, there has been one report of Entamoeba suis from a gorilla (Gorilla gorilla) [14], but 266 
whether this is a natural host for this Entamoeba species remains to be established. This species 267 
also produces cysts with a single nucleus.  268 
 269 
Missing Entamoeba Species? 270 
 271 
Perhaps surprisingly, there are to date no reports of E. moshkovskii from NHPs. This organism 272 
is actually a species complex with substantial intra-specific sequence variation [40] and is 273 
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being reported from humans with increasing frequency now that PCR-based detection is being 274 
employed [e.g. 41-43]. Entamoeba moshkovskii has also been detected in cattle, elephants [34], 275 
reptiles [44] and insects [Silberman JD, personal communication], so it is likely only a matter 276 
of time before it is also found in NHPs. Not all published molecular studies have tested for this 277 
species and in those that did it is not clear whether the primers used would detect all variants 278 
of this genetically diverse species complex. The most recently described Entamoeba of 279 
humans, E. bangladeshi [13], is also yet to be reported from NHPs. 280 
 281 
Entamoeba gingivalis, which colonises the gingival pockets in the mouth of humans, is listed 282 
as having been found in NHPs [e.g. in 45]. No molecular data are available to know whether 283 
the organisms reported in NHPs differ from those in humans. This may be important, as there 284 
are at least two SSU-rDNA variants of E. gingivalis in humans [40] and additional diversity 285 
could exist in other hosts.    286 
 287 
A summary of the relationships between species names and identifiers can be found in Table 288 
1 and an outline phylogenetic tree depicting the relationships between Entamoeba SSU-rDNA 289 
sequences is depicted in Figure 1.  290 
 291 
Captive vs. Wild NHPs 292 
 293 
Data on the presence and prevalence of Entamoeba species in NHPs is patchy at best, and most 294 
reports are based on animals in zoological parks. This is a problem when it comes to 295 
interpreting the data. The first issue is how to interpret the presence of parasites in captive 296 
NHPs. Animals in captivity may be exposed to organisms they would never encounter in the 297 
wild. Therefore, the data only indicate that the NHP species is capable of becoming colonised 298 
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by the parasite identified, not that it is a natural host for this parasite. A second issue is the 299 
impact of captivity on prevalence. It is likely that animals come in contact with faeces and 300 
faecal contamination of food and water more frequently in captivity than they would in the 301 
wild; this is especially true of species that are primarily or exclusively arboreal. Only by 302 
studying wild NHPs can ‘natural’ infections be identified, although in the case of peri-urban 303 
and urban NHPs the possibility of infection through contact with human faeces cannot be 304 
excluded. It is, of course, also likely that wild NHPs will ingest faeces from other hosts, 305 
accidentally or on purpose. If the ingested faeces contains Entamoeba cysts it is possible that 306 
DNA of these organisms will be detected when the NHP faeces is screened by PCR. However, 307 
unless the NHP species ingests faeces frequently and in significant amounts it would be 308 
unlucky if the small amount of NHP faeces analysed contained detectable DNA of Entamoeba 309 
cysts that were just passing through. 310 
 311 
Relatively few studies of Entamoeba in wild NHPs have employed molecular diagnostics to 312 
date, and microscopy does not differentiate most of the known Entamoeba species: only E. 313 
histolytica, E. coli and E. chattoni are regularly reported in publications reliant on microscopy. 314 
Each of these names actually represents a mixture of distinct organisms united only by the 315 
number of nuclei in their mature cyst. Entamoeba hartmanni is the only additional species that 316 
can be identified by morphology, but only if cyst diameters are measured; often this is either 317 
not the case or the information is not given. As a result, only studies employing sequence-based 318 
identification will be discussed below. We recognise that this excludes the vast majority of 319 
studies, but if the data are not interpretable we feel they are better omitted. 320 
 321 
Molecular studies in wild NHPs published to date (Table 2) are few in number, mostly involve 322 
Old World NHPs, and vary in the methodology used. In some studies, species-specific PCR 323 
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has been used, but often not all known species were tested for despite primers being available, 324 
leaving gaps in the data (Table 2, notes). When species-specific PCR has been used, this often 325 
means subtypes were not identified and potentially interesting data on sequence variation and 326 
host range have been lost. Several studies did not test for E. hartmanni, leading to a false 327 
impression of the distribution of this Entamoeba species in NHPs. It is notable that E. 328 
histolytica was not detected in any of these studies. 329 
 330 
The use of only species-specific primers can mean that novel Entamoeba species are missed. 331 
For example, if Villanueva-García et al. [39] had used species-specific primers for Entamoeba, 332 
the two novel Entamoeba species found in Howler monkeys (CL8 and RL6) would not have 333 
been identified – the samples would have appeared negative even though Entamoeba 334 
organisms were present. Sequencing of products amplified using genus-specific primers may 335 
seem the best way forward, but there is a catch. NHPs are often carriers of multiple Entamoeba 336 
species and mixed PCR products give unreadable sequences with the standard DNA 337 
sequencing. The approach of Jirků-Pomajbíková et al. [46] could be a good compromise – 338 
genus-specific amplification coupled with nested species-specific PCR. This allows 339 
identification of species in mixed infections yet does not miss mono-infections with novel 340 
Entamoeba species, as these would be positive with genus-specific but negative with all the 341 
species-specific primers used. Jirků-Pomajbíková et al. [46] did not initially test for E. 342 
hartmanni but through sequencing discovered that it was the Entamoeba present in the samples 343 
positive with the genus-specific primers but negative with the species-specific primer pairs 344 
used. However, this method will only identify the presence of novel Entamoeba species if they 345 
are present as a single infection unless it is combined with cloning of the PCR products.  346 
 347 
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It seems likely that identification of Entamoeba in NHPs in the future will be through 348 
microbiome data, whether from targeted amplification and sequencing of a portion of 349 
eukaryotic SSU-rDNA or by extraction of such sequences from metagenomic data. Both 350 
approaches are in use in humans and have identified Entamoeba when present, but to date have 351 
rarely been applied to NHP samples. In one example, Wegener Parfrey et al. [47] identified E. 352 
hartmanni (among many other eukaryotes) in captive NHPs through eukaryote-targeted SSU-353 
rDNA amplification and 454 sequencing. Similarly, random sequencing of faecal DNA has the 354 
potential to identify not only all the species present, but could enable assembly of partial or 355 
complete genomes for the organisms identified [e.g. 48]. While such approaches are expensive 356 
and likely to be available only to a few at present, the holistic information on the eukaryome 357 
of NHPs likely to be obtained by such approaches makes them very attractive and we look 358 
forward to seeing the data emerge in the next few years. 359 
 360 
Concluding Remarks 361 
 362 
Currently, at least six Entamoeba species with valid published names have been confirmed by 363 
molecular analysis in NHPs: E. coli, E. polecki, E. histolytica, E. nuttalli, E. dispar and E. 364 
hartmanni. However, in addition there are multiple subtypes within E. coli and E. polecki, plus 365 
organisms with no name but distinct gene sequences (Entamoeba RL3, RL6, RL7 and CL8). 366 
This remarkable expansion in known diversity has been driven largely by the use of molecular 367 
techniques that have facilitated the identification of many novel and previously unrecognised 368 
Entamoeba species in NHPs. 369 
 370 
However, many points remain to be clarified (see “Outstanding Questions”). It is unclear 371 
whether E. moshkovskii, E. bangladeshi and E. gingivalis colonise NHPs as well as humans. 372 
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Novel sequences with no linked species name are likely to continue to be detected in NHPs 373 
around the world. This search for new types of Entamoeba in NHPs is essential as it remains 374 
to be proven whether only E. nuttalli is responsible for morbidity and mortality in these hosts. 375 
However, unless the correct approaches are used, such organisms will remain undiscovered.  376 
 377 
We now know that NHPs are infected by both NHP-restricted and human-infective Entamoeba 378 
species. Morphological diagnosis of Entamoeba species will always be problematic, but most 379 
molecular approaches used to date may also be considerably underestimating the prevalence, 380 
diversity, and distribution of Entamoeba in NHPs. At the same time, insufficient taxon 381 
sampling and the heavy focus on humans may well have led us to inaccurate conclusions about 382 
Entamoeba evolution. Fortunately, interest in the eukaryotic microbiome is growing in parallel 383 
with improvements in technology, and it is likely that within the next few years a better 384 
understanding of the evolution and host ranges of Entamoeba in NHPs will emerge.  385 
 386 
Metagenomic analyses could allow the use of genes other than SSU-rDNA for phylogenetic 387 
analyses. Obtaining sequence data for other genes is difficult - if not impossible - using 388 
traditional molecular approaches and DNA from faecal samples. Multigene phylogenies may 389 
well provide greater resolution that could confirm or refute our current views of relationships 390 
within Entamoeba. Greater resolution is essential for evaluating the relative importance of 391 
cospeciation and host-switching in the evolution of primate Entamoeba species. It seems likely 392 
that these data will start to become available in the near future. 393 
 394 
A recent study showed a significant reduction in the gut microbiome diversity of captive NHPs, 395 
with a shift occurring from a wild NHP microbiome state toward a modern human microbiome 396 
state [49]. Whether alterations in the lifestyle and diet of captive NHPs or the disruption of 397 
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normal hierarchical social behavior [50] has led to this perturbation of their gut microbiome, 398 
the change may predispose captive NHPs to infection with certain Entamoeba spp, normally 399 
confined to humans. Comparison of gut microbiomes across NHPs living in the wild, 400 
semicaptivity and captivity using sequencing of both bacteria and Entamoeba SSU rDNA, is 401 
already possible. Such data will allow us to investigate the correlation between microbiota 402 
signatures and prevalence of specific Entamoeba species in NHPs. 403 
 404 
There is much more to learn regarding both the microbiome and the eukaryome of NHPs, 405 
especially those in the wild. There has been a strong focus on Old World primates, in particular 406 
macaques, while New World primates are significantly underrepresented and prosimians have 407 
not been studied. It is hoped that the range of species sampled will broaden, otherwise we will 408 
continue to have a rather limited view of Entamoeba diversity in NHPs. 409 
 410 
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Glossary 603 
 604 
Conditional lineage (CL): an Entamoeba identified as likely to be distinct based on 605 
sequencing of partial SSU-rDNA, but for which sufficient data are not yet available. See RL, 606 
below. 607 
 608 
Isoenzymes: each of two or more sequence variants of an enzyme that exhibit different 609 
migration in electrophoresis gels due to charge differences. 610 
 611 
Non-human primates (NHPs): all members of the order Primates other than humans; NHPs 612 
share many similarities with humans in terms of physiology, anatomy, immunology, and 613 
neurology, but are very diverse in their ecology, diet, etc. The split between humans and NHPs 614 
is an artificial one, as humans are much more closely related to some NHPs than others. 615 
 616 
Ribosomal lineage (RL): an Entamoeba taxon identified as distinct by sequencing of its 617 
complete SSU-rDNA gene. Often no corresponding morphological data are available. In 618 
other groups of organisms these are often called operational taxonomic units (OTUs) but in 619 
this case, it is clear that they belong to the genus Entamoeba. 620 
 621 
Small subunit ribosomal RNA gene (SSU-rDNA): the gene encoding the smaller of the two 622 
major RNA components of the ribosome, also known as 18S rDNA. This gene is the most 623 
widely used single locus for phylogenetic analyses in eukaryotes and bacteria. In Entamoeba, 624 
the gene size generally falls between 1800 and 2200 bases.  625 
 626 
Subtype: a discrete genetic clade within a named species.  627 
27 
 
Figure 1: Phylogenetic relationships among Entamoeba species. The phylogenetic tree 628 
shown is modified from Figure 1 in Jacob et al. [34]. Names in bold lettering are those that 629 
have been identified by sequencing of SSU-rDNA in NHPs. Adjacent to the Entamoeba names 630 
are those of the NHP species (wild or captive) in which the Entamoeba has been identified. 631 
 632 
633 
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Dobell nomenclaturea Current species names Identified in primates (incl. humans) Molecular identification in NHPs 
E. histolytica E. histolytica E. histolytica Yb 
 E. dispar E. dispar Y 
 E. hartmanni E. hartmanni Y 
 E. nuttalli E. nuttalli Y 
 E. moshkovskii E. moshkovskii (complex) N 
 E. polecki E. polecki ST1 c N 
  E. polecki ST4 Y 
 E. chattoni E. polecki ST2 Y 
 E. struthionis E. polecki ST3 N 
 E. bangladeshi E. bangladeshi N 
 E. suis E. suis Yb 
    
E. coli E. coli E. coli ST1 Yb 
  E. coli ST2 Y 
    
E. gingivalis E. gingivalis E. gingivalis ribodeme 1 d N 
  E. gingivalis ribodeme 2 N 
    
 None Entamoeba RL3 e Y 
  Entamoeba RL6 Y 
  Entamoeba RL7 Y 
  Entamoeba CL8 f Y 
 
Table 1. Correspondence between historic, binomial, and sequence-based nomenclature for Entamoeba species in primates.  
a Dobell’s nomenclature is that proposed in his 1919 monograph [3].  
bIdentified in captive NHPs only, to date. 
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c Subtypes (ST) are distinct small-subunit ribosomal DNA sequence variants that clearly fall within a named species.  
d Ribodemes are small-subunit ribosomal DNA variants detected by restriction enzymes.  
e Ribosomal (RL) [14] ] lineages indicate complete small-subunit ribosomal DNA sequences that are clearly distinct from all named species. 
f Conditional (CL) [34] lineages indicate partial small-subunit ribosomal DNA sequences that are clearly distinct from all named species.  
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NHP species Type of amplification 
Total no. of 
samples Species identified (no. of samples) Reference Notes 
Rhesus macaques (Macaca 
mulatta) 
Species-specific 715 
E. nuttalli (440), E. dispar (16), E. coli 
(574), E. polecki ST2 (649) 
51 a 
Rhesus macaque (Macaca 
mulatta) 
Species-specific 112 
E. nuttalli (57), E. dispar (13), E. coli 
(83), E. polecki ST2 (96) 
26 b 
Tibetan macaque (Macaca 
thibetana) 
Species-specific 89 
E. nuttalli (15), E. coli (37), E. polecki 
ST2 (59) 
52 c 
Savannah woodland 
chimpanzee (Pan 
troglodytes schweinfurthii) 
Genus- and species-
specific 
107 
E. hartmanni (32), E. dispar (10), E. 
coli ST2 (33) 
46 d 
Celebes crested macaque 
(Macaca nigra) 
Species/subtype-
specific 
77 E. polecki ST4 (75) 35 e 
Toque macaque (Macaca 
sinica) 
Species-specific 227 
E. nuttalli (42), E. dispar (1), E. coli 
(40), E. polecki ST2 (197) 
24 f 
Rhesus macaque (Macaca 
mulatta) 
Genus- and species-
specific 
128 
E. coli (63), unidentified Entamoeba 
(65) 
53 g 
Mountain gorilla (Gorilla 
beringei beringei) 
Genus-specific 68 E. coli ST2 (4), E. hartmanni (33) 36 h 
Howler monkeys (Alouatta 
palliata and A. pigra) 
Genus-specific 155 
Entamoeba CL8 (6 from A. pigra, 1 
from A. palliata), Entamoeba RL6 (1 
from A. pigra) 
39 i 
 
Table 2. Summary of results from molecular screening of faecal samples from wild NHP populations* 
* The publication by Dong et al. [54] includes data on several NHP species in China (mostly Macaca mulatta and M. fascicularis) but it is not 
possible to identify which results came from sampling wild populations. Samples were tested by species-specific amplification for E. histolytica, 
31 
 
E. nuttalli, E. dispar, E. moshkovskii, E. coli, and E. polecki ST2. Only E. coli and E. dispar were detected. No tests for E. hartmanni or other E. 
polecki subtypes were performed. 
a: Authors also tested captive macaques; these are excluded from the table. Tested for E. histolytica, E. dispar, E. nuttalli, E. coli, and E. polecki 
ST2 only. No test for E. hartmanni, E. moshkovskii or other E. polecki subtypes. 
b: Tested for E. histolytica, E. dispar, E. nuttalli, E. moshkovskii, E. coli, and E. polecki ST2 only. No test for E. hartmanni or other E. polecki 
subtypes. 
c: Tested for E. histolytica, E. dispar, E. nuttalli, E. coli, and E. polecki ST2 only. No test for E. hartmanni, E. moshkovskii or other E. polecki 
subtypes.  
d: Genus-PCR-positive samples were tested for E. histolytica, E. nuttalli, E. dispar, E. moshkovskii, E. coli, and E. polecki ST2. Genus-PCR 
positive, but species-specific PCR negative samples were sequenced and identified as E. hartmanni. 
e: Tested for E. histolytica, E. dispar, E. nuttalli, E. moshkovskii, E. coli, and E. polecki ST1, ST2 and ST4. No test for E. hartmanni or E. polecki 
ST3.  
f: Tested for E. histolytica, E. dispar, E. nuttalli, E. moshkovskii, E. coli, and E. polecki ST2. No test for E. hartmanni or other E. polecki subtypes. 
g: Genus-PCR positive samples were tested for E. coli. Multiplex PCR for E. histolytica, E. dispar and E. moshkovskii on all samples. No test for 
E. nuttalli, E. polecki, or E. hartmanni. 
h: Sequencing of Genus-PCR positive amplicons identified only these two species.   
i: Sequencing of Genus-PCR positive amplicons identified only these two organisms.  
